0.26 (1.53%) 1d
TG Therapeutics

Developing drugs for MS and blood cancers like leukemia. Exciting prospects; boasts promising clinical trial results, especially for their MS drug. Last month, they announced good phase 3 results for that drug which lifted share from the $30's to $50's. Cash flow is fine; they just said they've raised a lot of money.

TG Therapeutics
A biopharma. Dont sell. Great CEO. It took a long time, but the stock is now paying off.
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

TG Therapeutics(TGTX-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for TG Therapeutics is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

TG Therapeutics(TGTX-Q) Frequently Asked Questions

What is TG Therapeutics stock symbol?

TG Therapeutics is a American stock, trading under the symbol TGTX-Q on the NASDAQ (TGTX). It is usually referred to as NASDAQ:TGTX or TGTX-Q

Is TG Therapeutics a buy or a sell?

In the last year, there was no coverage of TG Therapeutics published on Stockchase.

Is TG Therapeutics a good investment or a top pick?

TG Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for TG Therapeutics.

Why is TG Therapeutics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is TG Therapeutics worth watching?

0 stock analysts on Stockchase covered TG Therapeutics In the last year. It is a trending stock that is worth watching.

What is TG Therapeutics stock price?

On 2024-05-24, TG Therapeutics (TGTX-Q) stock closed at a price of $16.72.